AE, B., H, S., G, T., S, F., S, A., & S, M. (2025). Comparative safety of ustekinumab versus anti-TNF therapy during pregnancy in patients with inflammatory bowel disease: A systematic review and meta-analysis. Medicine, 104(37), e44393. https://doi.org/10.1097/MD.0000000000044393
Chicago Style (17th ed.) CitationAE, Bardak, Saeed H, Teker G, Friedman S, Alsakarneh S, and Mitev S. "Comparative Safety of Ustekinumab Versus Anti-TNF Therapy During Pregnancy in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis." Medicine 104, no. 37 (2025): e44393. https://doi.org/10.1097/MD.0000000000044393.
MLA (9th ed.) CitationAE, Bardak, et al. "Comparative Safety of Ustekinumab Versus Anti-TNF Therapy During Pregnancy in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis." Medicine, vol. 104, no. 37, 2025, p. e44393, https://doi.org/10.1097/MD.0000000000044393.